Activ Surgical, which makes hardware-agnostic software for minimally invasive surgical systems, raises $45M Series B led by Cota Capital
Emma Betuel / TechCrunch :
Context & Ripple Effects
Activ Surgical's 2020 raise of $15M had left it with $32M in disclosed funding for an AI-enabled service giving surgeons real-time visualization and intelligence during minimally invasive procedures. This $45M Series B under Cota Capital roughly triples that war chest, and the pitch has sharpened since: the software is explicitly hardware-agnostic, designed to sit on top of whatever minimally invasive system a hospital already runs rather than requiring Activ to sell its own devices.
The raise lands in a segment where capital has been consolidating around a few well-funded players — Caresyntax pulled a $180M Series C extension for surgical data analysis just weeks before this round was reported, and Carlsmed closed a $52.5M Series C earlier in 2024 for personalized-surgery AI. Hardware-agnostic positioning is Activ's differentiator against both those data-platform peers and the incumbent robotics vendors whose systems bundle software with hardware.
First-order effects
- Cota Capital's lead check gives Activ Surgical the runway to pursue integration deals with multiple surgical-device manufacturers at once instead of building its own hardware — the direct payoff of the agnostic strategy.
- Hospitals running mixed fleets of laparoscopic and robotic systems become addressable customers immediately, since Activ's product does not require them to standardize on one vendor's platform.
Second-order effects
- Robotics vendors whose margins depend on bundling proprietary software with their instruments now face a third-party intelligence layer that hospitals can bolt onto their existing equipment, pressuring those bundles on price.
- With Caresyntax and Carlsmed raising nine-figure and eight-figure rounds respectively in the same window, competing surgical-AI startups face a rising capital bar to stay credible with hospital buyers evaluating platforms.
Third-order effects
- If hardware-agnostic surgical software proves out commercially, the industry splits into a device layer and an intelligence layer, letting hospitals buy visualization and analytics independently of which robot they operate — a structural unbundling of the integrated-system model.
- The pattern also points toward surgical data becoming the contested asset: whoever aggregates real-time procedure data across heterogeneous hardware accumulates the training corpus that next-generation surgical AI depends on, making cross-vendor deployment strategically decisive rather than merely convenient.
The trend: Surgical AI funding is consolidating into large-scale rounds for software layers that decouple intelligence from proprietary hardware, shifting value in minimally invasive surgery from the robot itself to the data and visualization stack above it.